BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hammerbacher J, Snyder A. Informatics for cancer immunotherapy. Ann Oncol 2017;28:xii56-73. [PMID: 29253114 DOI: 10.1093/annonc/mdx682] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Bichmann L, Nelde A, Ghosh M, Heumos L, Mohr C, Peltzer A, Kuchenbecker L, Sachsenberg T, Walz JS, Stevanović S, Rammensee H, Kohlbacher O. MHCquant: Automated and Reproducible Data Analysis for Immunopeptidomics. J Proteome Res 2019;18:3876-84. [DOI: 10.1021/acs.jproteome.9b00313] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
2 Eklund AC, Szallasi Z. Computational prediction of neoantigens: do we need more data or new approaches? Ann Oncol 2018;29:799-801. [PMID: 29481589 DOI: 10.1093/annonc/mdy070] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
3 Lin B, Wang S, Yao Y, Shen Y, Yang H. Comprehensive co-expression analysis reveals TMC8 as a prognostic immune-associated gene in head and neck squamous cancer. Oncol Lett 2021;22:498. [PMID: 33981360 DOI: 10.3892/ol.2021.12759] [Reference Citation Analysis]
4 Sankin A, Chand D, Schoenberg M, Zang X. Human urothelial bladder cancer generates a clonal immune response: The results of T-cell receptor sequencing. Urol Oncol 2019;37:810.e1-5. [PMID: 31103336 DOI: 10.1016/j.urolonc.2019.04.011] [Reference Citation Analysis]
5 Li L, Miao Q, Meng F, Li B, Xue T, Fang T, Zhang Z, Zhang J, Ye X, Kang Y, Zhang X, Chen Q, Liang X, Chen H, Zhang X. Genetic engineering cellular vesicles expressing CD64 as checkpoint antibody carrier for cancer immunotherapy. Theranostics 2021;11:6033-43. [PMID: 33897897 DOI: 10.7150/thno.48868] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Ebrahimi N, Akbari M, Ghanaatian M, Roozbahani Moghaddam P, Adelian S, Borjian Boroujeni M, Yazdani E, Ahmadi A, Hamblin MR. Development of neoantigens: from identification in cancer cells to application in cancer vaccines. Expert Rev Vaccines 2021;:1-15. [PMID: 34196590 DOI: 10.1080/14760584.2021.1951246] [Reference Citation Analysis]
7 Siano M, Espeli V, Mach N, Bossi P, Licitra L, Ghielmini M, Frattini M, Canevari S, De Cecco L. Gene signatures and expression of miRNAs associated with efficacy of panitumumab in a head and neck cancer phase II trial. Oral Oncol 2018;82:144-51. [PMID: 29909889 DOI: 10.1016/j.oraloncology.2018.05.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
8 Washah HN, Salifu EY, Soremekun O, Elrashedy AA, Munsamy G, Olotu FA, Soliman ME. Integrating Bioinformatics Strategies in Cancer Immunotherapy: Current and Future Perspectives. CCHTS 2020;23:687-98. [DOI: 10.2174/1386207323666200427113734] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Melero I, Navarro B, Teijeira A, Coukos G. Cancer immunotherapy full speed ahead. Annals of Oncology 2017;28:xii1-2. [DOI: 10.1093/annonc/mdx739] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
10 Caracciolo D, Riillo C, Arbitrio M, Di Martino MT, Tagliaferri P, Tassone P. Error-prone DNA repair pathways as determinants of immunotherapy activity: an emerging scenario for cancer treatment. Int J Cancer 2020;147:2658-68. [PMID: 32383203 DOI: 10.1002/ijc.33038] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Wei XL, Ren C, Wang FH, Zhang Y, Zhao HY, Zou BY, Wang ZQ, Qiu MZ, Zhang DS, Luo HY, Wang F, Yao S, Xu RH. A phase I study of toripalimab, an anti-PD-1 antibody, in patients with refractory malignant solid tumors. Cancer Commun (Lond) 2020;40:345-54. [PMID: 32589350 DOI: 10.1002/cac2.12068] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
12 Liu Z, Cai C, Du J, Liu B, Cui L, Fan X, Wu Q, Fang J, Xie L. TCMIO: A Comprehensive Database of Traditional Chinese Medicine on Immuno-Oncology. Front Pharmacol 2020;11:439. [PMID: 32351388 DOI: 10.3389/fphar.2020.00439] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]